-
Cumberland Pharmaceuticals announced positive cardiac results from Phase 2 trial in Duchenne
Cumberland Pharmaceuticals announced positive cardiac results from Phase 2 trial in Duchenne Cumberland Pharmaceuticals released […]
-
Entrada Therapeutics gets ok to start Exon 44 skipping trial in UK
As an early funder of Entrada, CureDuchenne is pleased to share that Entrada received authorization […]
-
To a parent, the years always seem too short
I read a quote the other day on Facebook: “When you are raising babies, you […]
-
CureDuchenne Announces Educational Events for Families and Caregivers of Individuals with Duchenne or Becker Muscular Dystrophy
Upcoming Events Offer Treatment Updates and Essential Resources to Support Families and Enhance Quality of […]
